Extracellular Vesicles Derived from Gut Microbiota, Especially Akkermansia muciniphila, Protect the Progression of Dextran Sulfate Sodium-Induced Colitis
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Gut microbiota play an important part in the pathogenesis of mucosal inflammation, such as inflammatory bowel disease (IBD). However, owing to the complexity of the gut microbiota, our understanding of the roles of commensal and pathogenic bacteria in the maintenance of immune homeostasis in the gut is evolving only slowly. Here, we evaluated the role of gut microbiota and their secreting extracellular vesicles (EV) in the development of mucosal inflammation in the gut. Experimental IBD model was established by oral application of dextran sulfate sodium (DSS) to C57BL/6 mice. The composition of gut microbiota and bacteria-derived EV in stools was evaluated by metagenome sequencing using bacterial common primer of 16S rDNA. Metagenomics in the IBD mouse model showed that the change in stool EV composition was more drastic, compared to the change of bacterial composition. Oral DSS application decreased the composition of EV from Akkermansia muciniphila and Bacteroides acidifaciens in stools, whereas increased EV from TM7 phylum, especially from species DQ777900_s and AJ400239_s. In vitro pretreatment of A. muciniphila-derived EV ameliorated the production of a pro-inflammatory cytokine IL-6 from colon epithelial cells induced by Escherichia coli EV. Additionally, oral application of A. muciniphila EV also protected DSS-induced IBD phenotypes, such as body weight loss, colon length, and inflammatory cell infiltration of colon wall. Our data provides insight into the role of gut microbiota-derived EV in regulation of intestinal immunity and homeostasis, and A. muciniphila-derived EV have protective effects in the development of DSS-induced colitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies also revealed the protective effects of A. muciniphila-derived extracellular vesicles in DSS-induced colitis.28”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364 · cited 1×
“commensal bacteria in genetically susceptible individuals [3].”
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“As some bacteria are being investigated for its protective qualities in regards to the human immunity, other microbiota have generated interest in their pathogenic features that link them to certain diseases [27].”
BackgroundCommensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“muciniphila (ATCC BAA-835) was cultured in an anaerobic condition that was maintained to 90% N2 and 10% CO2, the method previously described [20].”
BackgroundMethodThe immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 1×
“human intestines; however, in CD and UC, there is a large reduction in the number of these bacteria [21].”
BackgroundRapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Comparative Analysis of Human Gut Microbiota by Barcoded Pyrosequencing
Andersson, A. F., Lindberg, M., Jakobsson, H., Bäckhed, F., Nyrén, P., & Engstrand, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002836 · Cited by 1,038
Cited by
Items 201–300 of 542
Carvalho, R. D. D. O., Vaz, A. B. M., Pereira, F. L., Dorella, F. A., Aguiar, E. R. G. R., Chatel, J., Bermúdez‐Humarán, L. G., Langella, P., Fernandes, G. D. R., Figueiredo, H. C. P., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33469-w · Cited by 52
Zhang, P., Jiao, H., Wang, C., Lin, Y., & You, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00325 · Cited by 58
Cho, K., Kang, S. A., Kim, S., Mun, S. J., Yu, H. S., & Roh, H. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101500 · Cited by 52
Xu, N., Bai, X., Cao, X., Yue, W., Jiang, W., & Yu, Z. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104707 · Cited by 59
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases
Shen, H., Zhao, Z., Zhao, Z., Chen, Y., & Zhang, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020594 · Cited by 58
Hole, M. J., Jørgensen, K. K., Holm, K., Braadland, P. R., Meyer‐Myklestad, M. H., Medhus, A. W., Reikvam, D. H., Götz, A., Grzyb, K., Boberg, K. M., et al. (2023) · Hepatology · doi:10.1002/hep.32773 · Cited by 55
“muciniphila have been shown to alleviate experimentally induced colitis and protect epithelial integrity.[50] It has also been shown to exhibit protective properties against metabolic disease,[51] overall suggesting that A.”
BackgroundChen, P. P., Zhang, J. X., Li, X. Q., Li, L., Wu, Q. Y., Liu, L., Wang, G. H., Ruan, X. Z., & Ma, K. L. (2023) · Theranostics · doi:10.7150/thno.84650 · Cited by 57
“It has been demonstrated that Escherichia coli-derived OMVs induced more severe cytotoxicity, intracellular caspase-11 and LPS interaction, and inflammation in peritoneal macrophages compared with a single LPS treatment [46, 47].”
Moosavi, S. M., Sepahi, A. A., Mousavi, S. F., Vaziri, F., & Siadat, S. D. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00605-1 · Cited by 57
“muciniphila–derived EVs could disrupt disease progression [71].”
Present and Future Therapeutic Approaches to Barrier Dysfunction
Fortea, M., Albert-Bayo, M., Abril-Gil, M., Mall, J. G., Serra-Ruiz, X., Henao-Paez, A., Expósito, E., González-Castro, A. M., Guagnozzi, D., Lobo, B., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.718093 · Cited by 57
Akkermansia muciniphila - friend or foe in colorectal cancer?
Gubernatorova, E. O., Gorshkova, E. A., Bondareva, M. A., Podosokorskaya, O. A., Sheynova, A. D., Yakovleva, A. S., Bonch-Osmolovskaya, E. A., Nedospasov, S. A., Kruglov, A., & Drutskaya, M. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1303795 · Cited by 57
Tingler, A. M., & Engevik, M. A. (2025) · Infection and Immunity · doi:10.1128/iai.00503-24 · Cited by 68
Spinal cord injury and gut microbiota: A review
Jing, Y., Bai, F., & Yu, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118865 · Cited by 50
Wu, Z.-Y., Pan, D., Jiang, M., Sang, L.-X., & Chang, B. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.716816 · Cited by 57
Extracellular molecular effectors mediating probiotic attributes
Ruiz, L., Hevia, A., Bernardo, D., Margolles, A., & Sánchez, B. (2014) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12576 · Cited by 46
“For instance, extracellular vesicles secreted by the gut microbiota have been shown to have a therapeutic effect on an IBD mouse model (Kang et al., 2013).”
BackgroundDagnelie, M., Corvec, S., Khammari, A., & Dréno, B. (2019) · Experimental Dermatology · doi:10.1111/exd.14050 · Cited by 50
Strain-specific effects of Akkermansia muciniphila on the regulation of intestinal barrier
Liu, Y., Liu, Q., Zhang, C., Zhao, J., Zhang, H., Chen, W., & Zhai, Q. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.02.022 · Cited by 47
Maccelli, A., Carradori, S., Puca, V., Sisto, F., Lanuti, P., Crestoni, M. E., Lasalvia, A., Muraro, R., Bysell, H., Sotto, A. D., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8111653 · Cited by 49
Kim, J. R., Han, K., Han, Y., Kang, N., Shin, T.-S., Park, H. J., Kim, H., Kwon, W., Lee, S., Kim, Y.-K., et al. (2021) · Biology · doi:10.3390/biology10030219 · Cited by 52
Niu, G., Jian, T., Gai, Y., & Chen, J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114774 · Cited by 47
Zhang, P., Lu, G., Sun, Y., Yan, Z., Zhang, L., & Liu, J. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134147 · Cited by 48
Kameli, N., Borman, R., López‐Iglesias, C., Savelkoul, P. H. M., & Stassen, F. R. M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.667987 · Cited by 53
Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV
Behrouzi, A., Mazaheri, H., Falsafi, S., Tavassol, Z. H., Moshiri, A., & Siadat, S. D. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00511-6 · Cited by 50
“Numerous examinations have assessed the restorative capability of specific microbes, including commensal and probiotic strains, to enhance IBD in clinical preliminaries [11, 12] or in vitro models of colitis [28, 47, 48, 56, 57].”
BackgroundCirculating 16S RNA in Biofluids: Extracellular Vesicles as Mirrors of Human Microbiome?
Ricci, V., Carcione, D., Messina, S., Colombo, G. I., & D’Alessandra, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238959 · Cited by 50
“In their conclusions, the authors claimed to be the first to use EV-derived 16S detection to analyze the composition of gut microbiota-derived EV, introducing a great leap towards a better understanding of complex microbial populations, particularly of those microbes which were either difficult or impossible to cultiv…”
BackgroundHealth and Disease:Akkermansia muciniphila, the Shining Star of the Gut Flora
Xue, C., Li, G., Gu, X., Su, Y., Zheng, Q., Yuan, X. H., Bao, Z., Lu, J., & Li, L. (2023) · Research · doi:10.34133/research.0107 · Cited by 52
“muciniphiladerived EVs, Amuc_1100, and Amuc_2109 can significantly reduce colitis activity; alleviate colonic tissue damage and splenomegaly; and alleviate colonic infiltration by macrophages, CD8 cytotoxic T lymphocytes (CTLs), inflammatory factors, TNF-α, IFNγ, and other infiltrating factors [22,106,123,124].”
Mottawea, W., Yousuf, B., Sultan, S., Ahmed, T. A., Yeo, J., Hüttmann, N., Li, Y., Bouhlel, N. E., Hassan, H., Zhang, X., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01368-24 · Cited by 49
“Moreover, the same authors observed an attenuating effect of Akkermansia muciniphila -derived MEVs on colitis severity (19), suggesting the potential of MEVs as a biomarker and therapeutic agent.”
Vargoorani, M. E., Modarressi, M. H., Vaziri, F., Motevaseli, E., & Siadat, S. D. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00495-3 · Cited by 46
Pirolli, N. H., Reus, L. S. C., Mamczarz, Z., Khan, S., Bentley, W. E., & Jay, S. M. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28522 · Cited by 41
“…of an emerging class of biotechnology products that have utility as vaccines and therapeutics against infections, chronic inflammatory diseases, and cancer (Caruana & Walper, 2020; Carvalho et al., 2019; Chen et al., 2010; Chena et al., 2016; Rappazzo et al., 2016; Sung Kang et al., 2013).”
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin
Szymczak-Pajor, I., Drzewoski, J., Kozłowska, M., Krekora, J., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18010055 · Cited by 46
“It is well known that IL-6 has pro-inflammatory effect and attenuates insulin signaling in adipocytes [224–226].”
Castro-Mejía, J. L., Jakesevic, M., Krych, Ł., Nielsen, D. S., Hansen, L. H., Sondergaard, B. C., Kvist, P. H., Hansen, A. K., & Holm, T. L. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/4953120 · Cited by 45
16S rDNA microbiome composition pattern analysis as a diagnostic biomarker for biliary tract cancer
Lee, H., Lee, H. K., Min, S. K., & Lee, W. H. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-1793-3 · Cited by 44
Ye, L., Wang, Y., Xiao, F., Wang, X., Li, X., Cao, R. Y., Zhang, J., & Zhang, T. (2023) · Microbial Cell Factories · doi:10.1186/s12934-023-02243-7 · Cited by 43
“…the oral administration of EVs from the probiotic Akker-mansia muciniphila could ameliorate DSS-induced IBD phenotypes, such as body weight loss, colon length shortening, and inflammatory cell infiltration in the colon wall, and reduce the production of proinflammatory factors (such as IL-6) [42].”
BackgroundThe role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD
Cheng, Z., Yang, L., & Chu, H. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.002 · Cited by 47
“In contrast, the exosomes derived from commensal or probiotic microbiota, especially Akkermansia muciniphila , confer protection against diseases through reducing intestinal permeability, alleviating inflammation, and modulating lipid metabolism [130–132].”
Khalili, L., Nagpal, R., Park, G., & Salazar, G. (2024) · Microorganisms · doi:10.1016/j.cdnut.2024.102205 · Cited by 51
Colitis susceptibility in p47 phox−/− mice is mediated by the microbiome
Falcone, E. L., Abusleme, L., Swamydas, M., Lionakis, M. S., Ding, L., Hsu, A. P., Zelazny, A. M., Moutsopoulos, N. M., Kuhns, D. B., Deming, C., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0159-0 · Cited by 41
“muciniphila-derived extracellular vesicles reduces IBD severity [16].”
Health Monitoring of Laboratory Rodent Colonies—Talking about (R)evolution
Buchheister, S., & Bleich, A. (2021) · Animals · doi:10.3390/ani11051410 · Cited by 52
Kotelevets, L., & Chastre, E. (2023) · Cancers · doi:10.3390/cancers15041107 · Cited by 43
Satokari, R. M. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.966320 · Cited by 45
“coli-induced production of a proinflammatory cytokine IL-6 in enterocytes [78] and fortifies epithelial barrier function by inducing the tightening of enterocyte monolayer [79].”
BackgroundMicrobiota‐derived extracellular vesicles and metabolic syndrome
Villard, A., Boursier, J., & Andriantsitohaina, R. (2021) · Acta Physiologica · doi:10.1111/apha.13600 · Cited by 44
Roles of bacterial extracellular vesicles in systemic diseases
Wang, Y., Luo, X., Xiang, X., Hao, C., & Ma, D. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1258860 · Cited by 48
“Bacterial extracellular vesicles exhibit regulatory effects on intestinal immunity and homeostasis, as evidenced by stool BEVs from an IBD mouse model showing severe dysbiosis compared to that of the normal controls (Kang et al., 2013).”
BackgroundLopetuso, L. R., Quagliariello, A., Schiavoni, M., Petito, V., Russo, A., Reddel, S., CHIERICO, F. D., Ianiro, G., Scaldaferri, F., Neri, M., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.05.020 · Cited by 42
The emerging role of bacterial extracellular vesicles in human cancers
Liang, A., Korani, L., Yeung, C. L. S., Tey, S. K., & Yam, J. W. P. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12521 · Cited by 45
“…been shown to alleviate the production of pro-inflammatory cytokines such as IL-6, IFN-γ and C-reactive protein in colonic epithelial cells, while increasing the levels of anti-inflammatory cytokines such as IL-10, IL-13 and angiotensin-converting enzyme 2 (Kang et al., 2013, Wang et al., 2023).”
BackgroundKosciow, K., & Deppenmeier, U. (2019) · MicrobiologyOpen · doi:10.1002/mbo3.796 · Cited by 39
“…ative effect of A. muciniphila at some circumstances, such as an ex‐ acerbation of gut inflammation in Salmonella typhimurium‐infected gnotobiotic mice or the potentially harmful effect in conditions of a disrupted epithelial barrier (Ganesh, Klopfleisch, Loh, & Blaut, 2013; Kang et al., 2013).”
BackgroundTarashi, S., Zamani, M. S., Omrani, M. D., Fateh, A., Moshiri, A., Saedisomeolia, A., Siadat, S. D., & Kubow, S. J. (2022) · Journal of Immunology Research · doi:10.1155/2022/8092170 · Cited by 42
Direct Action of Non-Digestible Oligosaccharides against a Leaky Gut
Mavrogeni, M. E., Asadpoor, M., Henricks, P. A. J., Keshavarzian, A., Folkerts, G., & Braber, S. (2022) · Nutrients · doi:10.3390/nu14214699 · Cited by 38
“Other structures secreted by the gut microbiota are the extracellular vesicles (EVs) or outer membrane vesicles (OMVs), which are produced by Gram-negative bacteria, and are lipid bilayer vesicles associated with bacteria-host communication [135,136].”
BackgroundChoi, H.-I., Kim, M., Jeon, J., Han, J. K., & Kim, K.-S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.152 · Cited by 36
Green Tea Encourages Growth of Akkermansia muciniphila
Jeong, H. W., Kim, J. K., Kim, A. Y., Cho, D., Lee, J., Choi, J. K., Park, M., & Kim, W.-G. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2019.4662 · Cited by 40
“29,35,36 Thus, we also analyzed EVs from the cecum-derived stools.”
Shinde, T., Vemuri, R., Shastri, S., Perera, A. P., Gondalia, S. V., Beale, D. J., Karpe, A. V., Eri, R. D., & Stanley, R. A. (2020) · Nutrients · doi:10.3390/nu12082380 · Cited by 38
“A beneficial effect of Akkermansia on colitis, however, is effected by its extracellular vesicles that were found to protect against DSS-induced colitis [71].”
BackgroundHow does carrageenan cause colitis? A review
Guo, J., Shang, X., Chen, P., & Huang, X. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120374 · Cited by 43
Akkermansia muciniphila extracellular vesicles have a protective effect against hypertension
Kim, J. Y., Kim, C.-W., Oh, S. Y., Jang, S., Olarinoye, Z. Y., Kim, B. A., Hong, S., & Kim, I. (2024) · Hypertension Research · doi:10.1038/s41440-024-01627-5 · Cited by 41
“The isolation of EVs was performed as previously described [3, 19].”
Zhou, B.-G., Liu, F., Zhao, H., Zhang, X., Wang, H.-Y., & Liu, D. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113211 · Cited by 36
Recent advances and health implications of dietary fasting regimens on the gut microbiome
Mohr, A. E., Gumpricht, E., Sears, D. D., & Sweazea, K. L. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00475.2020 · Cited by 39
Shen, N., Chen, N., Zhou, X., Zhao, B., Huang, R., Liang, J., Yang, X., Chen, M., Song, Y., & Du, Q. (2018) · Bone · doi:10.1016/j.bone.2018.11.017 · Cited by 39
Luo, Y., Wu, J., Zhu, F., Wu, J., Wu, P., & Liu, Y. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s352467 · Cited by 36
“In addition, the quantity of Verrucomicrobia could be decreased due to reduced mucins in patients with UC, which constitute an energy source for this bacteria.(45) After using GCXX, the relative abundance of Proteobacteria slightly decreased and the relative abundance of Patescibacteria and Verrucomicrobia slightly in…”
BackgroundJeong, J., Ganesan, R., Jin, Y.-J., Park, H., Min, B. H., Jeong, M. K., Yoon, S. J., Choi, M., Choi, J., Moon, J. H., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1174968 · Cited by 40
A Review of Applied Aspects of Dealing with Gut Microbiota Impact on Rodent Models
Hansen, A. K., Krych, Ł., Nielsen, D. S., & Hansen, C. H. F. (2015) · ILAR Journal · doi:10.1093/ilar/ilv010 · Cited by 38
“A. muciniphila also seems to be protective against human IBD (Png et al. 2010) and DSS colitis in mice (Kang et al. 2013).”
BackgroundVillamil, S. I., Huerlimann, R., Morianos, C., Sarnyai, Z., & Maes, G. E. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.11.008 · Cited by 38
Millien, V. O., Rosen, D. G., Hou, J. K., & Shah, R. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5313-z · Cited by 38
Preparation and preservation of viable Akkermansia muciniphila cells for therapeutic interventions
Ouwerkerk, J. P., Aalvink, S., Belzer, C., & De Vos, W. M. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0096 · Cited by 33
Bacterial membrane vesicles in the pathogenesis and treatment of inflammatory bowel disease
Olovo, C. V., Ocansey, D. K. W., Ji, Y., Huang, X., & Xu, M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2341670 · Cited by 36
“150 While several miRNAs are associated with disease origin and development, some have been found to be pathology-specific.”
Extracellular Vesicles—Oral Therapeutics of the Future
Cieślik, M., Nazimek, K., & Bryniarski, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147554 · Cited by 40
“muciniphila-derived EVs triggered a protective effect against IBD, which was manifested in a reduction in weight loss and colon inflammation [43].”
BackgroundOlivo-Martínez, Y., Bosch, M., Badía, J., & Baldomà, L. (2023) · Nutrients · doi:10.3390/nu15112437 · Cited by 36
Meng, Q., Guo, J., Lv, K., Liu, Y., Zhang, J., Li, M., Cheng, X., Chen, S., Huo, X., Zhang, Q., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.02.020 · Cited by 34
“Previous studies revealed the protective effects of extracellular vesicles derived from Akkermansia muciniphila in DSS-induced colitis 71 .”
Zhuang, J., Zhuang, Z., Chen, B., Yang, Y., Chen, H., & Guan, G. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01063-2 · Cited by 40
“Additionally, an in vivo study based on mice revealed that Akkermansia muciniphila -derived EVs could attenuate DSS-induced colon length shortening, body weight loss, and so on (Kang et al. 2013).”
Li, Y., Liu, M., Zhou, J., Hou, B., Su, X.-H., Liu, Z., Yuan, J., & Li, M. (2019) · Beneficial Microbes · doi:10.3920/bm2018.0122 · Cited by 34
Total flavone of Abelmoschus Manihot improves colitis by promoting the growth of Akkermansia in mice
Bu, F., Ding, Y., Chen, T., Wang, Q., Wang, R., Zhou, J., Jiang, F., Zhang, D., Xu, M., Shi, G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00070-7 · Cited by 37
Bacterial extracellular vesicles in the initiation, progression and treatment of atherosclerosis
Lin, Y., Wang, J., Bu, F., Zhang, R., Wang, J., Wang, Y., Huang, M., Huang, Y., Zheng, L., Wang, Q., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2452229 · Cited by 36
“105 These studies suggest that in an existing inflammatory environment, the application of live bacteria may disturb the balance of intestinal ecology even further.”
Luo, Y., Lan, C., Xie, K., Li, H., Devillard, E., He, J., Liu, L., Cai, J., Tian, G., Wu, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.788638 · Cited by 37
“muciniphila is increases the level of 2-arachidonoylglycerol and in turn reduces the inflammatory responses in mice receiving a high-fat diet (10) and relieve dextran sulfate sodium (DSS)-induced colitis via its extracellular vesicles (43).”
BackgroundYoon, H., Kim, N.-E., Park, J., Shin, C. M., Kim, N., Lee, D. H., Park, J. Y., Choi, C. H., Kim, J. G., & Park, Y. S. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.112 · Cited by 31
“A previous study suggested that EVs derived from Akkermansia muciniphila prevent the progression of colitis in a mouse model [20].”
Hong, M.-G., Song, E., Yoon, H. J., Chung, W., Seo, H. Y., Kim, D., Lee, D., Seo, J., Lee, H., Kim, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57631-x · Cited by 33
“3C) 41 – 44 .”
Kazemzadeh, M., Hisey, C. L., Dauros‐Singorenko, P., Swift, S., Zargar‐Shoshtari, K., Xu, W., & Broderick, N. G. R. (2021) · IEEE Sensors Journal · doi:10.1109/jsen.2021.3131527 · Cited by 31
Sasso, G. L., Phillips, B. W., Sewer, A., Battey, J. N. D., Kondylis, A., Talikka, M., Titz, B., Guedj, E., Peric, D., Bornand, D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60175-3 · Cited by 33
Wu, Q., Kan, J., Fu, C., Liu, X., Cui, Z., Wang, S., Le, Y., Li, Z., Liu, Q., Zhang, Y., et al. (2024) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2024.100301 · Cited by 45
“…strategies for BEVs primarily utilize ultra-high-speed centrifugation, density gradient centrifugation, and size exclusion chromatography (Coumans et al., 2017; Kang et al., 2013; Northrop Albrecht et al., 2022; Park et al., 2022; Tulkens, De Wever, et al., 2020; Tulkens, Vergauwen, et al., 2020).”
MethodHelminth-Based Product and the Microbiome of Mice with Lupus
Neuman, H., Mor, H., Bashi, T., Givol, O., Watad, ., Shemer, A., Volkov, A., Barshack, I., Fridkin, M., Blank, M., et al. (2019) · mSystems · doi:10.1128/msystems.00160-18 · Cited by 29
“creasing amounts of IL-6 in a dose-dependent manner (26).”
Jafari, B., Nejad, R. A. K., Vaziri, F., & Siadat, S. D. (2019) · Biologia · doi:10.2478/s11756-019-00229-8 · Cited by 34
Agista, A. Z., Rusbana, T. B., Islam, J., Ohsaki, Y., Sultana, H., Hirakawa, R., Watanabe, K., Nochi, T., Ardiansyah, A., Budijanto, S., et al. (2021) · Nutrients · doi:10.3390/nu13061869 · Cited by 30
Rhee, S. J., Kim, H.-Y., Lee, Y., Lee, H. J., Park, C. H. K., Yang, J., Kim, Y.-K., & Ahn, Y. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-93112-z · Cited by 32
Filip, R. (2021) · Cells · doi:10.3390/cells10113202 · Cited by 30
“muciniphila-derived EVs increased the production of IL-6 (a proinflammatory cytokine) from colon epithelial cells induced by Escherichia coli EVs [101].”
BackgroundDiet, commensal microbiota‐derived extracellular vesicles, and host immunity
Taitz, J., Tan, J. K., Potier‐Villette, C., Ni, D., King, N. J. C., Nanan, R. K. H., & Macia, L. (2023) · European Journal of Immunology · doi:10.1002/eji.202250163 · Cited by 32
Ahmed, I., Roy, B. C., Raach, R.-M. T., Owens, S. M., Xia, L., Anant, S., Sampath, V., & Umar, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206701 · Cited by 34
Metabolic modulation during intestinal fibrosis
Bos, S., & Laukens, D. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12882 · Cited by 30
Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies
Mohan, M., Okeoma, C. M., & Sestak, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155407 · Cited by 31
“Moreover, gut dysbiosis promotes inflammatory and metabolic disorders [109], which may be imprinted in gut or blood derived BMCs and EVs, such as seen in EVs from saccharibacteria, formerly known as TM7, Akkermansia muciniphila, Bacteroides acidifaciens bacteria [110], or Bacteroides fragilis-derived EVs [111].”
BackgroundAkkermansia muciniphila: The state of the art, 18 years after its first discovery
Iwaza, R., Wasfy, R. M., Dubourg, G., Raoult, D., & Lagier, J. (2022) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2022.1024393 · Cited by 38
Immune Cells and Microbiota Response to Iron Starvation
Chieppa, M., & Giannelli, G. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00109 · Cited by 28
Ghaderi, F., Sotoodehnejadnematalahi, F., Hajebrahimi, Z., Fateh, A., & Siadat, S. D. (2022) · Scientific Reports · doi:10.1038/s41598-022-13840-8 · Cited by 36
Panax notoginseng Alleviates Colitis via the Regulation of Gut Microbiota
Wang, L., Shao, L., Chen, M., Wang, L., Yang, P., Tan, F., Zhang, W., & Huang, W. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x23500076 · Cited by 28
How to Manipulate the Microbiota: Fecal Microbiota Transplantation
Fuentes, S., & de Vos, W. M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-31248-4_10 · Cited by 31
Marquez‐Paradas, E., Torrecillas-López, M., Barrera‐Chamorro, L., Rio-Vazquez, J. L. D., la Rosa, T. G., & la Paz, S. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1514726 · Cited by 37
The roles of extracellular vesicles in major depressive disorder
Li, Y., Gui, Y., Zhao, M., Chen, X., Li, H., Chen, T., Zhao, H., Jiang, C., Xu, P., Zhang, S., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1138110 · Cited by 36
Mei, L., Wang, J., Hao, Y., Zeng, X., Yang, Y., Wu, Z., & Ji, Y. S. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2416481 · Cited by 29
“For example, A. muciniphila -generated EVs have been contributed to the attenuation of inflammatory responses, as observed in murine models of dextran sulfate sodium (DSS)-induced colitis and LPS-treated macrophages (Kang et al. 2013; Zheng et al. 2023).”
Mun, S. J., Kang, S. A., Park, H.-K., Yu, H. S., Cho, K., & Roh, H. (2021) · Stem Cells International · doi:10.1155/2021/6686625 · Cited by 25
Bolsega, S., Bleich, A., & Basic, M. (2021) · Nutrients · doi:10.3390/nu13114173 · Cited by 29
Xue, K., Wang, L., & Liu, J. (2022) · Materials Advances · doi:10.1039/d2ma00420h · Cited by 28
Ye, W.-Y., & Cai, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07149-z · Cited by 33
“Extracellular vesicles facilitate interbacterial communication via membrane fusion while simultaneously reinforcing intestinal barrier function to alleviate oxidative damage [31, 32]; IV.”
Badi, S. A., Moshiri, A., Marvasti, F. E., Mojtahedzadeh, M., Kazemi, V., & Siadat, S. D. (2020) · PubMed Central · doi:10.22074/cellj.2020.6499 · Cited by 31
Iyaswamy, A., Lu, K., Guan, X.-J., Kan, Y., Su, C.-F., Liu, J., Jaganathan, R., Vasudevan, K., Paul, J., Thakur, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11072056 · Cited by 28
IL-17 is a protection effector against the adherent-invasive Escherichia coli in murine colitis
Zhang, H.-J., Xu, B., Wang, H., Xu, B., Wang, G., Jiang, M., Lei, C., Ding, M., Yu, P., Nie, Y., et al. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.11.020 · Cited by 27
“…straightforward potential means which colonized microbiota drive inflammation in mice with aberrant immune, the concept of a pathobiont promoting experimental colitis in a genetically susceptible host is in accordance with some previous literatures (Kang et al., 2013; Malik et al., 2016).”
ResultPreidis, G. A., Ajami, N. J., Wong, M. C., Bessard, B. C., Conner, M. E., & Petrosino, J. F. (2016) · Journal of Nutrition · doi:10.3945/jn.115.229179 · Cited by 31
The biofunction of Akkermansia muciniphila in intestinal-related diseases
Jiang, P., Ji, S., Su, D., Zhao, Y., Goncalves, V. B. E., Xu, G., & Zhang, M. (2024) · Microbiome Research Reports · doi:10.20517/mrr.2024.12 · Cited by 23
An Integrated Engineering Approach to Creating Health‐Modulating Postbiotics
Chikindas, M. L., Roopchand, D. E., Tiwari, S. K., Sichel, L. S., Karwe, M. V., Nitin, N., Fagundes, V. L., Popov, I. V., Tagg, J. R., Lu, X., et al. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70326 · Cited by 31
“The protection conferred by EVs is further supported by studies showing that A. muciniphila EVs ameliorated dextran sodium sulfate (DSS)-induced colitis phenotypes, including body weight loss, reduced colon length, and inflammatory infiltration [45].”
Bacterial extracellular vesicles: Emerging nanoplatforms for biomedical applications
Gurunathan, S., & Kim, J. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106308 · Cited by 24
Metadata
- Authors
- Kang, C.-S., Ban, M., Choi, E.-J., Moon, H.-G., Jeon, J.-S., Kim, D.-K., Park, S.-K., Jeon, S. G., Roh, T.-Y., Myung, S.-J., Gho, Y. S., Kim, J. G., & Kim, Y.-K.
- Affiliations
- Pohang University of Science and Technology (KR)
- Asan Medical Center (KR)
- Chung-Ang University Healthcare System (KR)
- Corresponding author
- Gho, Yong Song
- Kim, Jae Gyu
- Kim, Yoon-Keun
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-24
- Volume
- 8
- Issue
- 10
- Pages
- e76520
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3811976
- OpenAlex
- W2086465908
- Cited by
- 543
- References
- 36
- Citations by year
- 2026: 33 · 2025: 53 · 2024: 55 · 2023: 67 · 2022: 58 · 2021: 73 · 2020: 58 · 2019: 34 · 2018: 39 · 2017: 30 · 2016: 23 · 2015: 10 · 2014: 10
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Open Access System for Information Sharing (Pohang University of Science and Technology) (submittedVersion)
- Funders
- National Research Foundation
- Pohang University of Science and Technology
- Korea Research Institute of Bioscience and Biotechnology
- National Research Foundation of Korea (2011-0000879)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- extracellular vesicles, gut microbiota, Akkermansia muciniphila, DSS-induced colitis, inflammatory bowel disease, intestinal inflammation, Bacteroides acidifaciens, interleukin-6, Escherichia coli, intestinal immunity, intestinal homeostasis, commensal bacteria
- MeSH terms
- Animals, Colitis, Disease Models, Animal, Female, Inflammatory Bowel Diseases, Dextran Sulfate, Disease Progression, Secretory Vesicles, Mice, Metagenome, Bacterial Secretion Systems, Verrucomicrobia, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.